A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release: Results of the metoprolol succinate-felodipine antihypertension combination trial (M-FACT)

American Journal of Hypertension

Volumn 19, Issue 4, 2006, Pages 388-395

  Frishman, William H ^a,c   Hainer, James W ^b   Sugg, Jennifer ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c WESTCHESTER MEDICAL CENTER   (United States)

Author keywords

adrenergic receptor blockers; Antihypertensive therapy; Calcium channel blockers; Efficacy; Essential; Hypertension; Safety

Indexed keywords

FELODIPINE; METOPROLOL SUCCINATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEPTIC ULCER; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THORAX PAIN;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; METOPROLOL; MIDDLE AGED;

EID: 33645357525     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.10.007     Document Type: Article

References (22)

1. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. James, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure the JNC 7 report J Am Med Assoc 289 2003 2560 2572
2. ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) J Am Med Assoc 283 2000 1967 1975
3. M. Moser, H.R. Black The role of combination therapy in the treatment of hypertension Am J Hypertens 11 1998 73S 78S
4. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff, R.G. Marks, P. Kowey, F.H. Messerli, G. Mancia, J.L. Cangiano, D. Garcia-Barreto, M. Keltai, S. Erdine, H.A. Bristol, H.R. Kolb, G.L. Bakris, J.D. Cohen, W.W. Parmley INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial J Am Med Assoc 290 2003 2805 2816
5. R.B. Devereux, B. Dahlöf, S.E. Kjeldsen, S. Julius, P. Aurup, G. Beevers, J.M. Edelman, U. de Faire, F. Fyhrquist, S. Helle Berg, H. Ibsen, K. Kristianson, O. Lederballe-Pedersen, L.H. Lindholm, M.S. Nieminen, P. Omvik, S. Oparil, S. Snappin, H. Wedel LIFE Study Group Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease a substudy of the LIFE randomized trial Ann Intern Med 139 2003 169 177
6. H.R. Black, W.J. Elliott, G. Grandits, P. Grambsch, T. Lucente, W.B. White, J.D. Neaton, R.H. Grimm Jr, L. Hansson, Y. Lacourciere, J. Muller, P. Sleight, M.A. Weber, G. Williams, J. Wittes, A. Zanchetti, R.J. Anders CONVINCE Research Group Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial J Am Med Assoc 289 2003 2073 2082
7. L. Hansson, L.H. Lindholm, T. Ekbom, B. Dahlöf, J. Lanke, B. Schersten, P.O. Wester, T. Hedner, U. de Faire Randomised trial of old and new antihypertensive drugs in elderly patients cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study Lancet 354 1999 1751 1756
8. T. Ekbom, B. Dahlöf, L. Hannson, L.H. Lindholm, A. Oden, B. Schersten, P.O. Wester The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure - insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) Blood Press 1 1992 168 172
9. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlöf, D. Elmfeldt, S. Julius, J. Menard, K.H. Rahn, H. Wedel, S. Westerling HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 1998 1755 1762
10. J. Brun, L. Froberg, P. Kronmann, L.B. Olsson, P. Skoog, G. Tygesen, C. Bengtsson, B. Schersten, G. Tibblin Swedish General Practitioner Felodipine Study Group Optimal felodipine dose when combined with metoprolol in arterial hypertension a Swedish multicenter study within primary hesub care J Cardiovasc Pharmacol 15 Suppl 4 1990 S60 S64
11. B. Dahlöf, J. Hosie The Swedish/United Kingdom Study Group Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy J Cardiovasc Pharmacol 16 1990 910 916
12. L.M. Wing, A.E. Russell, A.L. Tonkin, A.J. Bune, M.J. West, J.P. Chalmers Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly Blood Press 3 1994 82 89
13. R.D. Gordon, S.A. Klemm, T.J. Tunny, J.R. Wicks, D.B. Elmfeldt Effects of felodipine, metoprolol and their combination on blood pressure at rest and during exercise and on volume regulatory hormones in hypertensive patients Blood Press 4 1995 300 306
14. O.K. Andersson Swedish Multicentre Group Improved efficacy with maintained tolerability in the treatment of primary hypertension. Comparison between the felodipine-metoprolol combination tablet and monotherapy with enalapril J Hum Hypertens 13 1999 55 60
15. B. Dahlöf, L. Jönsson, O. Borgholst, G. Ekblad, C. Engstrand, I. Grundestam, A. Lindh Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone Blood Press 2 Suppl 1 1993 37 45
16. B. Dahlöf, J. Hosie Swedish/United Kingdom Study Group Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances monotherapy J Cardiovasc Pharmacol 16 1990 910 916
17. J. Hoffman, Y. Fox German Multicentre Study Group Efficacy and tolerability of the fixed combination of felodipine 5 mg plus metoprolol 50 mg in comparison with the individual components in the treatment of hypertension J Drug Devel 3 1991 201 207
18. P.H. Westfall, S.Y. Ho, B.A. Prillaman Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials J Biopharm Stat 11 2001 125 138
19. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
20. P. Trenkwalder, D. Elmfeldt Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs - the rationale and benefits of combining felodipine and metoprolol J Hum Hypertens 9 Suppl 2 1995 S37 S42
21. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: Draft ICH Consensus Principle Principles for Clinical Evaluation of New Antihypertensive Drugs 2000 March 2, Available at: http://www.fda.gov/cder/guidance/3774dft.htm. Accessed May 2004
22. R.R. Fenichel, R.J. Lipicky Combination products as first-line pharmacotherapy Arch Intern Med 154 1994 1429 1430